Early detection saves lives

CEDAR’s mission is profound: to detect and stop lethal cancers at the earliest stage. This ambitious goal requires a different approach to cancer research.

We are an innovative team of more than 160 researchers with expertise in a wide range of fields, from computational biology to nanotechnology to molecular biology. As part of the OHSU Knight Cancer Institute, we have access to top-flight technology and resources.

CEDAR’s impact

Since our founding in 2017, CEDAR has earned a reputation as a world leader in early detection. We have:

• Authored 137 early detection publications, most with an impact factor of 10 or more.
• Enrolled over 6,600 people in clinical trials.
• Invested in cancer education and prevention through our Healthy Oregon Project, which has enrolled 40,000 participants.
• Filed 54 invention disclosures, 16 provisional patents and two U.S. patents.
• Incubated five potential start-up companies.
• Collaborated with researchers around the globe to bring the promise of early detection to more people.